Rockwell Medical, Inc. (RMTI)
NASDAQ: RMTI · Real-Time Price · USD
0.890
+0.044 (5.24%)
Apr 28, 2026, 4:00 PM EDT - Market closed

Company Description

Rockwell Medical, Inc., together with its subsidiaries, engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide.

It offers citrapure citric acid concentrate, dri-sate dry acid concentrate, renalpure liquid acid concentrate, dri-sate acid concentrate mixer, renalpure acid concentrate, renalpure bicarbonate concentrate, sterilyte bicarbonate concentrate, bicarbonate cartridges, and dry acid concentrate mixer, as well as ancillary products, including 5% acetic acid, cleaner, citric acid descaler, water softener salt pellets, and other supplies used by hemodialysis providers.

The company’s hemodialysis concentrate products are used to sustain patient’s life by removing toxins and balancing electrolytes in a dialysis patient’s bloodstream.

In addition, it offers dialysis concentrates, dialysis kits, and other ancillary products used in the dialysis process.

The company was formerly known as Rockwell Medical Technologies, Inc. and changed its name to Rockwell Medical, Inc. in June 2012.

Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan.

Rockwell Medical, Inc.
Rockwell Medical logo
Country United States
Founded 1994
IPO Date Jan 27, 1998
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 157
CEO Mark Strobeck

Contact Details

Address:
30142 South Wixom road
Wixom, Michigan 48393
United States
Phone 248 960 9009
Website rockwellmed.com

Stock Details

Ticker Symbol RMTI
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001041024
CUSIP Number 774374300
ISIN Number US7743743004
Employer ID 38-3317208
SIC Code 2834

Key Executives

Name Position
Dr. Mark Strobeck Ph.D. President, Chief Executive Officer and Director
Jesse Neri Senior Vice President and Chief Financial Officer
Megan C. Timmins Executive Vice President, Chief Legal Officer and Secretary
Heather H. Hunter Senior Vice President and Chief Operating Officer
Nicholas Fanslau Controller and Principal Accounting Officer
Timothy T. Chole Senior Vice President and Chief Commercial Officer

Latest SEC Filings

Date Type Title
Apr 20, 2026 PRE 14A Other preliminary proxy statements
Mar 26, 2026 8-K Current Report
Mar 26, 2026 10-K Annual Report
Mar 26, 2026 8-K Current Report
Jan 20, 2026 8-K Current Report
Jan 5, 2026 144 Filing
Jan 5, 2026 8-K Current Report
Jan 2, 2026 144 Filing
Nov 18, 2025 144 Filing
Nov 18, 2025 8-K Current Report